Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Comment by Pandoraon Jul 07, 2022 11:55pm
106 Views
Post# 34810261

RE:Shares for debt

RE:Shares for debt

VANCOUVER, BC / ACCESSWIRE / July 7, 2022 / Verisante Technology, Inc. (NEX:VER.H) (the "Company") is pleased to announce that at the 2022 Annual General Meeting held on July 6, 2022, in Vancouver, British Columbia, the Company's shareholders voted in favour of all items of business. All director nominees were elected.

The shareholders approved resolutions to set the number of directors at four, and to elect Thomas Braun, Jake Thiessen, Emmeline Braun and Vincent Trinh to serve as directors until the next annual meeting or until their respective successors are duly elected and qualified.

The shareholders also ratified the appointment of the Company's auditors, Fernandez Young, LLP, as auditors of the Company and to accept the financial statements for the years ended December 31, 2017, 2018, 2019, 2020 and 2021 and to re-appoint the auditors for the year ended December 31, 2022.

<< Previous
Bullboard Posts
Next >>